{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:40:20Z","timestamp":1784133620361,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370255"],"award-info":[{"award-number":["82370255"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U24A20646"],"award-info":[{"award-number":["U24A20646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Science and Technology Commission Project","award":["23410761200"],"award-info":[{"award-number":["23410761200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11596-025-00096-2","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T05:49:13Z","timestamp":1753163353000},"page":"819-830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inflammation-Related Factors\u00a0S100A9 and TLR2 in Cardiomyocyte Hypertrophy"],"prefix":"10.1007","volume":"45","author":[{"given":"Ke-jia","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-xing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6718-9341","authenticated-orcid":false,"given":"Hui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"13","key":"96_CR1","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3390\/cells12131780","volume":"12","author":"F Bazgir","year":"2023","unstructured":"Bazgir F, Nau J, Nakhaei-Rad S, et al. The Microenvironment of the Pathogenesis of Cardiac Hypertrophy. Cells. 2023;12(13):1780.","journal-title":"Cells"},{"key":"96_CR2","doi-asserted-by":"publisher","first-page":"e13636","DOI":"10.1111\/cpr.13636","volume":"2024","author":"F Chen","year":"2024","unstructured":"Chen F, He Z, Wang C, et al. Advances in the study of S100A9 in cardiovascular diseases. Cell prolif. 2024:e13636.","journal-title":"Cell prolif"},{"issue":"41","key":"96_CR3","doi-asserted-by":"publisher","first-page":"e2403542","DOI":"10.1002\/advs.202403542","volume":"11","author":"H Lu","year":"2024","unstructured":"Lu H, Wang J, Chen Z, et al. Engineered Macrophage Membrane-Coated S100A9-siRNA for Ameliorating Myocardial Ischemia-Reperfusion Injury. Adv Sci (Weinh). 2024;11(41):e2403542.","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"96_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCULATIONAHA.118.039262","volume":"140","author":"Y Li","year":"2019","unstructured":"Li Y, Chen B, Yang X, et al. S100a8\/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic\/Reperfusion Injury. Circulation. 2019;140(9):751\u2013764.","journal-title":"Circulation."},{"issue":"13","key":"96_CR5","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.119.043833","volume":"141","author":"G Sreejit","year":"2020","unstructured":"Sreejit G, Abdel-Latif A, Athmanathan B, et al. Neutrophil-Derived S100A8\/A9 Amplify Granulopoiesis After Myocardial Infarction. Circulation. 2020;141(13):1080\u20131094.","journal-title":"Circulation."},{"issue":"10","key":"96_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028006","volume":"13","author":"YP Yuan","year":"2024","unstructured":"Yuan YP, Shen ZY, Teng T, et al. S100a8\/9 (S100 Calcium Binding Protein a8\/9) Promotes Cardiac Hypertrophy Via Upregulation of FGF23 (Fibroblast Growth Factor 23) in Mice. J Am Heart Assoc. 2024;13(10):e028006.","journal-title":"Journal of the American Heart Association."},{"key":"96_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/704202","volume":"2010","author":"F Arslan","year":"2010","unstructured":"Arslan F, Keogh B, McGuirk P, et al. TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm. 2010;2010:704202.","journal-title":"Mediators of inflammation."},{"issue":"2","key":"96_CR8","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201345R","volume":"37","author":"J Qian","year":"2023","unstructured":"Qian J, Liang S, Wang Q, et al. Toll-like receptor-2 in cardiomyocytes and macrophages mediates isoproterenol-induced cardiac inflammation and remodeling. FASEB J. 2023;37(2):e22740.","journal-title":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology."},{"issue":"1","key":"96_CR9","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1152\/ajpheart.00995.2008","volume":"296","author":"W Chao","year":"2009","unstructured":"Chao W. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart and Circ Physiol. 2009;296(1):H1\u2013H12.","journal-title":"American journal of physiology Heart and circulatory physiology."},{"issue":"1","key":"96_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3892\/mmr.2020.11104","volume":"22","author":"XY Zhang","year":"2020","unstructured":"Zhang XY, Huang Z, Li QJ, et al. Ischemic postconditioning attenuates the inflammatory response in ischemia\/reperfusion myocardium by upregulating miR\u2011499 and inhibiting TLR2 activation. Mol Med Rep. 2020;22(1):209\u2013218.","journal-title":"Molecular medicine reports."},{"issue":"3","key":"96_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/00365513.2020.1725977","volume":"80","author":"A Feren\u010di\u0107","year":"2020","unstructured":"Feren\u010di\u0107 A, Cuculi\u0107 D, Stemberga V, et al. Left ventricular hypertrophy is associated with overexpression of HSP60, TLR2, and TLR4 in the myocardium. Scand J Clin Lab Invest. 2020;80(3):236\u2013246.","journal-title":"Scandinavian journal of clinical and laboratory investigation."},{"key":"96_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trsl.2021.02.011","volume":"233","author":"S Ye","year":"2021","unstructured":"Ye S, Lin K, Wu G, et al. Toll-like receptor 2 signaling deficiency in cardiac cells ameliorates Ang II-induced cardiac inflammation and remodeling. Trans Res. 2021;233:62\u201376.","journal-title":"Translational research : the journal of laboratory and clinical medicine."},{"issue":"10","key":"96_CR13","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1253\/circj.CJ-11-0194","volume":"75","author":"S Mathur","year":"2011","unstructured":"Mathur S, Walley KR, Wang Y, et al. Extracellular heat shock protein 70 induces cardiomyocyte inflammation and contractile dysfunction via TLR2. Circ J. 2011;75(10):2445\u20132452.","journal-title":"Circulation journal : official journal of the Japanese Circulation Society."},{"issue":"20","key":"96_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012338","volume":"8","author":"P Liu","year":"2019","unstructured":"Liu P, Bao HY, Jin CC, et al. Targeting Extracellular Heat Shock Protein 70 Ameliorates Doxorubicin-Induced Heart Failure Through Resolution of Toll-Like Receptor 2-Mediated Myocardial Inflammation. J Am Heart Assoc. 2019;8(20):e012338.","journal-title":"Journal of the American Heart Association."},{"issue":"6","key":"96_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000267","volume":"2","author":"Y Higashikuni","year":"2013","unstructured":"Higashikuni Y, Tanaka K, Kato M, et al. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1\u03b2 upregulation via nuclear factor \u03baB activation. J Am Heart Assoc. 2013;2(6):e000267.","journal-title":"Journal of the American Heart Association."},{"key":"96_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijcard.2018.04.103","volume":"267","author":"RN Wu","year":"2018","unstructured":"Wu RN, Yu TY, Zhou JC, et al. Targeting HMGB1 ameliorates cardiac fibrosis through restoring TLR2-mediated autophagy suppression in myocardial fibroblasts. Int J Cardiol. 2018;267:156\u2013162.","journal-title":"International journal of cardiology."},{"issue":"8","key":"96_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1790","volume":"14","author":"J Qian","year":"2024","unstructured":"Qian J, Wang Q, Xu J, et al. Macrophage OTUD1-CARD9 axis drives isoproterenol-induced inflammatory heart remodelling. Clin and Transl Med. 2024;14(8):e1790.","journal-title":"Clinical and translational medicine."},{"issue":"3","key":"96_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.008550","volume":"15","author":"L Feng","year":"2022","unstructured":"Feng L, Li G, An J, et al. Exercise Training Protects Against Heart Failure Via Expansion of Myeloid-Derived Suppressor Cells Through Regulating IL-10\/STAT3\/S100A9 Pathway. Circ Heart Fail. 2022;15(3):e008550.","journal-title":"Circulation Heart failure."},{"key":"96_CR19","doi-asserted-by":"publisher","first-page":"1268675","DOI":"10.3389\/fcvm.2023.1268675","volume":"10","author":"X Luo","year":"2023","unstructured":"Luo X, Wang R, Zhang X, et al. Identification CCL2,CXCR2,S100A9 of the immune-related gene markers and immune infiltration characteristics of inflammatory bowel disease and heart failure via bioinformatics analysis and machine learning. Front Cardiovas Med. 2023;10:1268675.","journal-title":"Frontiers in cardiovascular medicine."},{"key":"96_CR20","doi-asserted-by":"crossref","unstructured":"Hong L, Cai X, Zhan Y, et al. TLR2 activates AP-1 to facilitate CTGF transcription and stimulate doxorubicin-induced myocardial injury. Br J Pharmacol. 2025;46(3):606\u2013617.","DOI":"10.1111\/bph.17423"},{"issue":"3","key":"96_CR21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41401-024-01415-4","volume":"46","author":"L Pan","year":"2025","unstructured":"Pan L, Yin C, Jin KJ, et al. Low-density lipoprotein receptor-related protein 6 ameliorates cardiac hypertrophy by regulating CTSD\/HSP90\u03b1 signaling during pressure overload. Acta Pharmacol Sin. 2025;46(3):606\u2013617.","journal-title":"Acta pharmacologica Sinica."},{"key":"96_CR22","doi-asserted-by":"crossref","unstructured":"Kumar S, Wang G, Zheng N, et al. HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis. Hypertension. 2019;73(5):1058\u20131070.","DOI":"10.1161\/HYPERTENSIONAHA.118.12267"},{"key":"96_CR23","doi-asserted-by":"crossref","unstructured":"Wei X, Wu B, Zhao J, et al. Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8\/A9. Circulation. 2015;131(17):1506\u20131517.","DOI":"10.1161\/CIRCULATIONAHA.114.013789"},{"issue":"5","key":"96_CR24","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCRESAHA.120.315865","volume":"127","author":"G Marinkovi\u0107","year":"2020","unstructured":"Marinkovi\u0107 G, Koenis DS, de Camp L, et al. S100A9 Links Inflammation and Repair in Myocardial Infarction. Circ Res. 2020;127(5):664\u2013676.","journal-title":"Circ Res."},{"key":"96_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.891570","volume":"13","author":"Y Zhai","year":"2022","unstructured":"Zhai Y, Ao L, Yao Q, et al. Elevated Expression of TLR2 in Aging Hearts Exacerbates Cardiac Inflammatory Response and Adverse Remodeling Following Ischemia and Reperfusion Injury. Front Immunol. 2022;13:891570.","journal-title":"Frontiers in immunology."},{"issue":"4","key":"96_CR26","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jhep.2013.12.005","volume":"60","author":"A Moles","year":"2014","unstructured":"Moles A, Murphy L, Wilson CL, et al. A TLR2\/S100A9\/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse. J Hepatol. 2014;60(4):782\u2013791.","journal-title":"Journal of hepatology."},{"issue":"32","key":"96_CR27","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1093\/eurheartj\/ehz461","volume":"40","author":"G Marinkovi\u0107","year":"2019","unstructured":"Marinkovi\u0107 G, Grauen Larsen H, Yndigegn T, et al. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction. Eur Heart J. 2019;40(32):2713\u20132723.","journal-title":"European heart journal."},{"issue":"5","key":"96_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/bph.15998","volume":"180","author":"B Bai","year":"2023","unstructured":"Bai B, Xu Y, Chen H. Pathogenic roles of neutrophil-derived alarmins (S100A8\/A9) in heart failure: From molecular mechanisms to therapeutic insights. Br J Pharmacol. 2023;180(5):573\u2013588.","journal-title":"British journal of pharmacology."},{"key":"96_CR29","doi-asserted-by":"publisher","first-page":"1365015","DOI":"10.3389\/fimmu.2024.1365015","volume":"15","author":"G De Luca","year":"2024","unstructured":"De Luca G, Goette NP, Lev PR, et al. Elevated levels of damage-associated molecular patterns HMGB1 and S100A8\/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis. Front Immunol. 2024;15:1365015.","journal-title":"Frontiers in immunology."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00096-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-025-00096-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00096-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:02:51Z","timestamp":1758772971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-025-00096-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1007\/s11596-025-00096-2","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All experimental protocols involving animals in this study were approved by the Animal Care and Use Committee of Zhongshan Hospital, Fudan University. All the human studies were approved by the ethics committee of Zhongshan Hospital, Fudan University (Approval No: B2021-886R).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}